Patients diagnosed with pulmonary tuberculosis should be treated according to the doctor's advice and strictly abide by the cross-treatment policy of "early, middle and full course of treatment, combined use and appropriate amount". As long as the treatment plan is correct and the treatment method is proper, most patients can be cured. Because anti-tuberculosis drugs have certain side effects, such as liver, kidney, nervous system, etc., it is necessary to review biochemical and other related tests regularly during the anti-tuberculosis process. For example, patients stop taking drugs without authorization, change drugs or doses, and take them by mistake. It may lead to treatment failure and even drug resistance. In the treatment of tuberculosis, the occurrence of drug resistance will increase the difficulty of treatment, prolong the treatment time and increase the treatment cost. It is also possible to spread multidrug-resistant tuberculosis to others and bring adverse effects to society.
Generally speaking, patients with drug-resistant tuberculosis will have repeated colds, chest pains and dyspnea. Due to chest pain and lesions. It involves the pleura. A few patients have a high fever. The main manifestations are cough, expectoration and sometimes hemoptysis. After the patient developed drug resistance. In terms of medication, other drugs need to be replaced for treatment. However, drug selection and medication plan must be carried out under the guidance of doctors.
If you have drug-resistant tuberculosis, it is very dangerous, because this drug resistance is combined with liver bacteria and does not produce resistance to any drugs, so there is no drug to treat this bacterial infection. The reason of tuberculosis drug resistance is that there is a certain antibody combination in long-term drug treatment, so we must pay attention to it and maintain a good attitude.
Tuberculosis itself is an infectious disease related to immunity and malnutrition. The clinical manifestations are weight loss, progressive edema or emaciation and various physical disorders. Therefore, in the treatment of drug-resistant patients with diabetes complicated with pulmonary tuberculosis, anti-tuberculosis drug sensitivity test should be carried out as soon as possible, and early diagnosis and treatment should be carried out, and nutrition should be given at any time according to the nutritional status of patients, so as to keep the nutritional balance of patients and support anti-tuberculosis treatment. Compared with ordinary drug-resistant tuberculosis patients, diabetic patients and newly diagnosed drug-resistant tuberculosis patients have lower resistance to health.